Inotek Pharmaceuticals Corporation Announces Closing Of Initial Public Offering And Convertible Senior Notes Offering

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (the “Company”) (NASDAQ: ITEK), today announced the closing of its initial public offering of 6,667,000 shares of its common stock at a price to the public of $6.00 per share for aggregate proceeds of $40 million, before underwriting discounts. All of the common stock is being offered by the Company. The Company’s shares are listed on the NASDAQ Global Market under the symbol “ITEK.”

Help employers find you! Check out all the jobs and post your resume.